Revision history of "Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer" (Q73395687)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

17 August 2024

3 May 2024

24 December 2022

4 November 2022

3 November 2022

18 October 2022

27 March 2022

2 March 2020

13 December 2019

7 November 2019

3 November 2019